The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions. Li X, Cheng L. Osteoporos Int 2025 Jan 15. doi: 10.1007/s00198-025-07389.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Cheng L. The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions. Osteoporos Int 2025 Jan 15. doi: 10.1007/s00198-025-07389.
PMID: 39812674